Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Inspire Medical Systems
INSP
$1.5B
| $30.6M | 0.03% |
172,746
+13,810
| +9% | +$2.78M |
|
|
LADR
252
Ladder Capital
LADR
$1.23B
| $30.3M | 0.03% |
3,386,509
+322,916
| +11% | +$3.56M |
|
253
East-West Bancorp
EWBC
$18.1B
| $30.3M | 0.03% |
450,856
+116,020
| +35% | +$8.25M |
|
254
Marvell Technology
MRVL
$196B
| $30.2M | 0.03% |
704,797
+46,519
| +7% | +$2.3M |
|
|
CTLT
255
DELISTED
CATALENT, INC.
CTLT
| $30.2M | 0.03% |
417,013
+54,368
| +15% | +$5.4M |
|
256
JD.com
JD
$44.5B
| $30.1M | 0.03% |
598,705
+150,453
| +34% | +$8.91M |
|
257
WSFS Financial
WSFS
$4.19B
| $30M | 0.03% |
645,334
-16,674
| -3% | -$779K |
|
258
MACOM Technology Solutions
MTSI
$19.5B
| $29.7M | 0.03% |
573,602
+28,370
| +5% | +$1.55M |
|
|
IMGN
259
DELISTED
Immunogen Inc
IMGN
| $29.6M | 0.03% |
+6,197,480
| New | +$32.7M |
|
|
NARI
260
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $29.5M | 0.03% |
406,037
-107,321
| -21% | -$7.99M |
|
261
JB Hunt Transport Services
JBHT
$25.1B
| $29M | 0.03% |
185,613
-37,974
| -17% | -$6.63M |
|
|
RVNC
262
DELISTED
Revance Therapeutics, Inc.
RVNC
| $28.9M | 0.03% |
1,072,235
-683,468
| -39% | -$13.9M |
|
263
Martin Marietta Materials
MLM
$32.6B
| $28.8M | 0.03% |
89,409
+4,402
| +5% | +$1.49M |
|
264
Datadog
DDOG
$103B
| $28.4M | 0.03% |
320,328
+72,914
| +29% | +$7.34M |
|
265
Phreesia
PHR
$698M
| $28.3M | 0.03% |
1,110,942
+394,599
| +55% | +$9.85M |
|
|
SPR
266
DELISTED
Spirit AeroSystems
SPR
| $28.1M | 0.03% |
1,282,101
+318,456
| +33% | +$9.68M |
|
267
Full Truck Alliance
YMM
$10.1B
| $28.1M | 0.03% |
4,283,750
-2,428,888
| -36% | -$18.7M |
|
|
HOLX
268
DELISTED
Hologic
HOLX
| $27.9M | 0.03% |
431,705
+7,881
| +2% | +$546K |
|
269
TotalEnergies
TTE
$193B
| $27.8M | 0.03% |
598,265
+84,943
| +17% | +$4.27M |
|
270
Core & Main
CNM
$8.56B
| $27.7M | 0.03% |
1,217,354
-137,042
| -10% | -$3.2M |
|
271
Bio-Rad Laboratories Class A
BIO
$8.96B
| $27.6M | 0.03% |
66,234
+1,399
| +2% | +$698K |
|
|
AESC
272
DELISTED
The AES Corporation
AESC
| $27M | 0.03% |
305,484
| – | – |
|
273
Avantor
AVTR
$9.25B
| $26.9M | 0.03% |
1,373,893
+299,010
| +28% | +$8.01M |
|
274
Jack Henry & Associates
JKHY
$11.1B
| $26.8M | 0.03% |
147,089
-131,371
| -47% | -$25.8M |
|
275
Shell
SHEL
$249B
| $26.6M | 0.03% |
535,338
-73,709
| -12% | -$3.8M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.